AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in AN2 Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −6 vs. Q1 2023
- Shares held
- 11.7M
- +2.15M (+22.4%) vs. Q1 2023
- Total value
- $99.9M
- +$5.21M (+5.5%) vs. Q1 2023
- New holders
- 8
- 3 more added
- Sold out
- 14
- 16 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 3,773,517 | $32.1M | 0.61% | 00.0% | Unchanged |
| BVF Inc | 1,563,963 | $13.3M | 0.37% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,336,983 | $11.4M | 0.01% | −1760.0% | Reduced |
| TCG Crossover Management, LLC | 1,289,320 | $11.0M | 1.80% | +1,289,320 | New |
| Janus Henderson Group PLC | 1,000,068 | $8.59M | 0.01% | +1,000,068 | New |
| Octagon Capital Advisors LP | 720,900 | $6.13M | 0.85% | +720,900 | New |
| Avidity Partners Management LP | 657,200 | $5.59M | 0.20% | −66,000−9.1% | Reduced |
| Vanguard Group Inc | 552,799 | $4.70M | 0.00% | −49,126−8.2% | Reduced |
| Monashee Investment Management LLC | 181,995 | $1.55M | 0.37% | −65,472−26.5% | Reduced |
| Citigroup Inc | 134,473 | $1.14M | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 98,426 | $836.6K | 0.01% | +50,000+103.3% | Added |
| Private Advisor Group, LLC | 67,500 | $573.8K | 0.00% | +45,492+206.7% | Added |
| Geode Capital Management, LLC | 52,962 | $450.2K | 0.00% | −91,985−63.5% | Reduced |
| UBS Group AG | 49,673 | $422.2K | 0.00% | −2,552−4.9% | Reduced |
| Morgan Stanley | 42,242 | $359.1K | 0.00% | −3,290−7.2% | Reduced |
| Goldman Sachs Group Inc | 39,107 | $332.4K | 0.00% | +39,107 | New |
| Bridgeway Capital Management, LLC | 27,500 | $233.8K | 0.01% | −25,000−47.6% | Reduced |
| Barclays PLC | 27,074 | $230.1K | 0.00% | −5,699−17.4% | Reduced |
| Millennium Management LLC | 24,242 | $206.1K | 0.00% | +24,242 | New |
| BlackRock Inc. | 23,482 | $199.6K | 0.00% | −459,947−95.1% | Reduced |
| Qube Research & Technologies Ltd | 18,361 | $156.1K | 0.00% | +18,361 | New |
| State Street Corp | 18,102 | $153.9K | 0.00% | −78,782−81.3% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 14,040 | $119.3K | 0.01% | +14,040 | New |
| Integrated Wealth Concepts LLC | 12,500 | $106.3K | 0.00% | +12,500 | New |
| Bank of America Corp | 12,216 | $103.8K | 0.00% | −13,700−52.9% | Reduced |
| Rhumbline Advisers | 1,677 | $14.3K | 0.00% | −10,033−85.7% | Reduced |
| FMR LLC | 670 | $5.70K | 0.00% | +363+118.2% | Added |
| Royal Bank of Canada | 186 | $2.00K | 0.00% | −456−71.0% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $1.70K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 101 | $859 | 0.00% | −5,778−98.3% | Reduced |
| Wells Fargo & Company | 35 | $298 | 0.00% | −1,931−98.2% | Reduced |
| Northern Trust Corp | 0 | $0 | 0.00% | −76,134−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −31,684−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −29,898−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −15,546−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −8,511−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −6,815−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −5,362−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −4,131−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,797−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,767−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,166−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |